We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App





Coronavirus More Likely to Infect People with Blood Type A, Finds Study

By HospiMedica International staff writers
Posted on 23 Mar 2020
A new preliminary study in China has found that people having blood type A could be more vulnerable to the coronavirus, while those having type O blood might be more resistant. More...
According to researchers from the Centre for Evidence-Based and Translational Medicine at Zhongnan Hospital of Wuhan University (Wuhan, China) who studied COVID-19 in its outbreak epicenter, Wuhan, and the city of Shenzhen, the proportion of Type-A patients both infected and killed by the coronavirus was found to be “significantly” higher than those with the same blood type among the general public. On the other hand, Type O patients comprised a smaller proportion of those who were infected as well as killed by the coronavirus.

In their study, the researchers compared the blood types of 2,173 confirmed coronavirus patients in Wuhan and Shenzhen with over 3,694 healthy residents in the Wuhan area. According to the published research, 31.16% of the residents in Wuhan had Type-A blood, as against 37.75% of the surveyed coronavirus patients at the Wuhan Jinyintan Hospital having the same blood type. Out of these surveyed coronavirus patients, 25.8% had Type-O blood, as compared to 33.84% of the general population, while 25.8% had Type-O blood, as against 33.84% of the general population. An examination of 206 patients who had died from the coronavirus revealed that 85 victims, or 41.26%, had Type-A blood, while only 52 victims, or about a quarter, had Type-O blood.

“People of blood group A might need particularly strengthened personal protection to reduce the chance of infection,” according to the researchers, who however termed the study as preliminary and stated that more work was needed to confirm the findings.

Related Links:
Centre for Evidence-Based and Translational Medicine at Zhongnan Hospital of Wuhan University


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.